Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse

Human Molecular Genetics

Volumn 12, Issue 22, 2003, Pages 2949-2956

  Lehman, Emily J H ^a,b   Kulnane, Laura Shapiro ^a,b   Gao, Yuan ^a,b   Petriello, Michelle C ^a,b   Pimpis, Karen M ^a,b   Younkin, Linda ^c   Dolios, Georgia ^d   Wang, Rong ^d   Younkin, Steven G ^c   Lamb, Bruce T ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c MAYO CLINIC   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID BETA PROTEIN; ISOPROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CONGENIC STRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENETIC ANALYSIS; GENETIC SCREENING; HEREDITY; INBRED STRAIN; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PROCESSING; TRANSGENIC MOUSE; YEAST ARTIFICIAL CHROMOSOME;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BRAIN; CHROMOSOMES, ARTIFICIAL, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; PRECIPITIN TESTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPECIES SPECIFICITY; TRANSGENES; VARIATION (GENETICS);

ANIMALIA; MUS MUSCULUS;

EID: 10744233138     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg322     Document Type: Article

References (40)

1. Cummings, J.L. and Cole, G. (2002) Alzheimer disease. JAMA, 287, 2335-2338.
2. Tanzi, R.E. and Bertram, L. (2001) New frontiers in Alzheimer's disease genetics. Neuron, 32, 181-184.
3. Selkoe, D.J. and Podlisny, M.B. (2002) Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet., 3, 67-99.
4. Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K. and Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733-736.
5. Greenfield, J.P., Gross, R.S., Gouras, G.K. and Xu, H. (2000) Cellular and molecular basis of β-amyloid precursor protein metabolism. Front. Biosci., 5, D72-83.
6. Lamb, B.T., Call, L.M., Slunt, H.H., Bardel, K.A., Lawler, A.M., Eckman, C.B., Younkin, S.G., Holtz, G., Wagner, S.L., Price, D.L. et al. (1997) Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum. Mol. Genet., 6, 1535-1541.
7. Lamb, B.T., Bardel, K.A., Kulnane, L.S., Anderson, J.J., Holtz, G., Wagner, S.L., Sisodia, S.S. and Hoeger, E.J. (1999) Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat. Neurosci., 2, 695-697.
8. Lehman, E.J.H., Kulnane, L.S. and Lamb, B.T. (2003) Alterations in β-amyloid production and deposition in brain regions of two transgenic models. Neurobiol. Aging, 24, 645-653.
9. Kulnane, L.S. and Lamb, B.T. (2001) Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice. Neurobiol. Dis., 8, 982-992.
10. Lamb, B.T., Sisodia, S.S., Lawler, A.M., Slunt, H.H., Kitt, C.A., Kearns, W.G., Pearson, P.L., Price, D.L. and Gearhart, J.D. (1993) Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nat. Genet., 5, 22-30.
11. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B. and Lannfelt, L. (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet., 1, 345-347.
12. Silver, L. (1995) Mouse Genetics Concepts and Applications. Oxford University Press, New York.
13. Boss, M.A. (2000) Diagnostic approaches to Alzheimer's disease. Biochim. Biophys. Acta, 1502, 188-200.
14. Golde, TE., Eckman, C.B. and Younkin, S.G. (2000) Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim. Biophys. Acta, 1502, 172-187.
15. De Jonghe, C., Cras, P., Vanderstichele, H., Cruts, M., Vanderhoeven, I., Smouts, I., Vanmechelen, E., Martin, J.J., Hendriks, L. and Van Broeckhoven, C. (1999) Evidence that Aβ42 plasma levels in presenilin-1 mutation carriers do not allow for prediction Of their clinical phenotype. Neurobiol. Dis., 6, 280-287.
16. Murayama, O., Tomita, T., Nihonmatsu, N., Murayama, M., Sun, X., Honda, T., Iwatsubo, T. and Takashima, A. (1999) Enhancement of amyloid β 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. Neurosci. Lett., 265, 61-63.
17. Qi, Y., Morishima-Kawashima, M., Sato, T., Mitsumori, R. and Ihara, Y. (2003) Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid β-protein 42 in Chinese hamster ovary cells. Biochemistry, 42, 1042-1052.
18. Troncoso, J.C., Martin, L.J., Dal Forno, G. and Kawas, C.H. (1996) Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol. Aging, 17, 365-371.
19. Lopez-Alberola, R.F., Barker, W.W., Harwood, D.G., Loewenstein, D.A., George-Hyslop, P.H., Tsuda, T., Rogaeva, E.A. and Duara, R. (1997) Interfamilial and intrafamilial phenotypic heterogeneity in familial Alzheimer's disease. J. Geriatr. Psychiatry Neurol., 10, 1-6.
20. (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol. Aging, 18, S1-2.
21. Snowdon, D.A. (1997) Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist, 37, 150-156.
22. Tunstall, N., Owen, M.J., Williams, J., Rice, F., Carty, S., Lillystone, S., Fraser, L., Kehoe, P., Neill, D., Rudrasingham, V. et al. (2000) Familial influence on variation in age of onset and behavioural phenotype in Alzheimer's disease. Br. J. Psychiat., 176, 156-159.
23. Lopera, F., Ardilla, A., Martinez, A., Madrigal, L., Arango-Viana, J.C., Lemere, C.A., Arango-Lasprilla, J.C., Hincapie, L., Arcos-Burgos, M., Ossa, J.E. et al. (1997) Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA, 277, 793-799.
24. Axelman, K., Basun, H. and Lannfelt, L. (1998) Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Arch. Neurol., 55, 698-702.
25. Gomez-Isla, T., Growdon, W.B., McNamara, M.J., Nochlin, D., Bird, T.D., Arango, J.C., Lopera, F., Kosik, K.S., Lantos, P.L., Cairns, N.J. et al. (1999) The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain, 122, 1709-1719.
26. Li, Y.J., Scott, W.K., Hedges, D.J., Zhang, F., Gaskell, P.C., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R. et al. (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am. J. Hum. Genet., 70, 985-993.
27. Brookmeyer, R., Gray, S. and Kawas, C. (1998) Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health, 88, 1337-1342.
28. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F. et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature, 373, 523-527.
29. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science, 274, 99-102.
30. Borchelt, D.R., Ratovitski, T., van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., Copeland, N.G., Price, D.L. and Sisodia, S.S. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron, 19, 939-945.
31. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P.A. et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl Acad. Sci. USA, 94, 13287-13292.
32. Janus, C., Pearson, J., McLaurin, J., Mathews, P.M., Jiang, Y., Schmidt, S.D., Chishti, M.A., Horne, P., Heslin, D., French, J. et al. (2000) Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature, 408, 979-982.
33. Carlson, G.A., Borchelt, D.R., Dake, A., Turner, S., Danielson, V., Coffin, J.D., Eckman, C., Meiners, J., Nilsen, S.P., Younkin, S.G. et al. (1997) Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum. Mol. Genet., 6, 1951-1959.
34. Chishti, M.A., Yang, D.S., Janus, C., Phinney, A.L., Home, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J. et al. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem., 276, 21562-21570.
35. DeMattos, R.B., Bales, K.R., Cummins, D.J., Dodart, J.C., Paul, S.M. and Holtzman, D.M. (2001) Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA, 98, 8850-8855.
36. Ertekin-Taner, N., Graff-Radford, N., Younkin, L.H., Eckman, C., Baker, M., Adamson, J., Ronald, J., Blangero, J., Huton, M. and Younkin, S.G. (2000) Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science, 290, 2303-2304.
37. Kulnane, L.S., Lehman, E.J., Hock, B.J., Tsuchiya, K.D. and Lamb, B.T. (2002) Rapid and efficient detection of transgene homozygosity by FISH of mouse fibroblasts. Mamm. Genome, 13, 223-226.
38. Suzuki, N., Cheung, T.T., Cai, X.D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. E. and Younkin, S.G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science, 264, 1336-1340.
39. Kawarabayashi, T., Younkin, L.H., Saido, T.C., Shoji, M., Ashe, K.H. and Younkin, S.G. (2001) Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci., 21, 372-381.
40. Wang, R., Sweeney, D., Gandy, S.E. and Sisodia, S.S. (1996) The profile of soluble amyloid β protein in cultured cell media. Detection and quantification of amyloid β protein and variants by immunoprecipitation-mass spectrometry. J. BioL. Chem., 271, 31894-31902.